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Crohn’s disease aﬀects any part of the GI tract, commonly the terminal ileum. To decrease radiation exposure we developed
a low-radiation-dose unenhanced CT (modiﬁed small Bowel CT, MBCT) to evaluate the small bowel using hyperdense oral
contrast. Technique. MBCT wasinvestigated in patients with pathologicallyproven Crohn’s diseasepresenting with new symptoms
from recurrent inﬂammation or stricture. After ethics board approval, 98 consecutive patients were retrospectively evaluated.
Kappa values from two independent reviewers were calculated for presence of obstruction, active inﬂammation versus chronic
stricture, and ancillary ﬁndings. Forty-two patients underwent surgery or colonoscopy within 3 months. Results. Kappa was 0.84
for presence of abnormality versus a normal exam and 0.89 for diﬀerentiating active inﬂammation from chronic stricture. Level
of agreement for presence of skip areas, abscess formation, and ﬁstula was 0.62, 0.75, and 0.78, respectively. In the subset with
“gold standard” follow-up, there was 83% agreement. Conclusions. MBCT is a low-radiation technique with good to very good
interobserver agreement for determining presence of obstruction and degree of disease activity in patients with Crohn’s disease.
Further investigation is required to reﬁne parameters of disease activity compared to CT enterography and small bowel follow
through.
1.Introduction
Crohn’s disease is an idiopathic, transmural, granulomatous
disease that can aﬀect any part of the gastrointestinal tract
from the mouth to the anus, but most often aﬀects the
terminal ileum [1]. These patients usually present during
their 2nd and 3rd decades with symptoms of pain, bloody
diarrhea, malabsorption, weight loss, and recurrent bowel
obstructions [2]. This younger patient population presents
with relapsing and remitting symptoms, and up to 80% of
patients with Crohn’s disease require surgery at some point
i nt h ec o u r s eo ft h e i rd i s e a s e[ 2].
Due to their recurrent symptoms, cross-sectional imag-
ing is often requested by the treating physicians in order
to identify the cause, allowing for appropriate treatment. In
cases of acute ﬂare-up, medical treatment is the best option,
whereas strictures often require surgical resection. Cross-
sectional imaging techniques evaluating this disease should
expose the patient to the least amount of radiation while still
being able to conﬁdently and reproducibly identify the area
involved, the presence of skip lesions, and whether the ﬁnd-
ings are related toacuteﬂare-up orduetochronic structures.
The purposes of this study were to retrospectively review
interobserver agreement about MBCT ﬁndings in patients
with recurrent symptoms of known Crohn’s disease.
2.Methods
At our institution, we have developed a modiﬁed small
bowel CT protocol which uses hyperdense oral contrast, 9%
ioxitalamic acid (Telebrix-38, Tyco healthcare, QC, Canada),
and a high noise index. A noise index of 28 is used
with Auto-mA modulation on 16- or 64-slice scanners (GE
Lightspeed, VCT LightSpeed (Germany)) compared to a
typical noise index of 12–18 for a standard abdominopelvic
CT scan. Image noise(GE Healthcare,noise index [NI])is an2 Gastroenterology Research and Practice
operator-selected variable which alters the range of mA over
which an automated tube current modulation varies during
gantry rotation [3]. The combination of high NI and Auto-
mA modulation reduces patient radiation dose in MBCT.
For the MBCT protocol, patients fast for 6 hours prior to
theexam.Nobowelpreparationornasogastric tubeinsertion
is needed. An oral solution of 9% Telebrix-38 (meglumine
ioxitalamate; Tyco healthcare, QC, Canada) is administered
compared to the 3% used as oral preparation in most
standard CT scans of the abdomen and pelvis. This solution
has a high attenuation (500–600HU), increasing contrast
resolutiononthisunenhancedCTprotocol.Hounsﬁeldunits
in excess of this would cause beam hardening artifacts. The
patient drinks 300mL aliquots of the oral contrast every 15
minutes over 60 minutes, for a total volume of 1200mL.
T h ei s o t o n i cn a t u r eo ft h e9 %o r a lc o n t r a s tg i v e sb e t t e r
distension of the bowel lumen compared to water or other
lower osmolal solutions, since there is physiologically less
absorption of this isotonic solution by the small bowel. This
allows more consistent distension of the small bowel, even
in patients without moderate or high-grade small bowel
obstruction.
Timing of the CT scan is determined on scout images,
since the hyperdense oral contrast is readily visualized in the
ascending colon, indicating complete small bowel opaciﬁca-
tion.
Other parameters include 120kV, mA range of 100 to
240mA, a 0.5 sec gantry rotation, and a pitch of 1, with slice
reconstruction of 0.5–1.25mm, depending on the scanner
used. Prone and supine scanning ensures opaciﬁcation of
all parts of the small bowel, but at the discretion of the
radiologist, the prone scan can be omitted, particularly in
follow-up studies. Images are viewed at a window of 800–
900HU and level of 200–300HU.
Reconstructed thin slices are postprocessed to produce
maximum intensity projections (MIP), multiplanar refor-
mats (MPR), and virtual endoscopy images, which have
been shown to increase diagnostic conﬁdence [4, 5]. Once
reformatted on a 3D workstation and viewed as thicker cuts,
the resultant images depict density diﬀerences between the
dense oral contrast in lumen of the small bowel, the grey
wall of the bowel, and the dark fat surrounding the bowel
as well as the dark grey appearing vasculature in the small
bowel mesentery. On average, reconstructions take less than
5 minutes but may require up to 20 minutes, depending on
the case’s complexity.
We performed a HIPPA compliant, REB-approved, ret-
rospective review of 98 consecutive patients with previously
diagnosed Crohn’s disease who presented for investigation
of new symptoms which were suspected to be due to either
inﬂammation or chronic stricture. The diagnosis of Crohn’s
disease was pathologically proven previously, either by sur-
gery or colonoscopy with ileal intubation and/or endoscopy
with biopsies.
Each modiﬁedsmall bowelCTimagesetswere retrospec-
tively reviewed by two radiologists in a blinded fashion: the
prior reports were not available to them and prior images
were not accessed. A standardized research form was ﬁlled
out which qualitatively evaluated the adequacy of bowel
distension, the degree of conﬁdence of the ﬁnal diagnosis,
whether or not the study was normal or abnormal, which
bowel segments were involvedand whether the ﬁndings were
consistent with acute inﬂammation or chronic stricture, and
existence of ancillary ﬁndings. Ancillary ﬁndings included
presence of abscesses, ﬁstula formation, and skip lesions;
each of these variables was independently documented.
Statistical analysis software was used to calculate the
kappa scores. The kappa statistics for interobserver agree-
ment for binary CT signs were interpreted using the fol-
lowingscale:fairagreement,0.21–0.40;moderateagreement,
0.41–0.60; substantial agreement, 0.61–0.80; and almost
perfect agreement, 0.81–1.0 [6].
3.Results
There were 49 men and 49 women with average age of 44
years old (range 22–88 years old). All had previously biopsy-
proved Crohn’s disease and were referred by a gastroenterol-
ogist or surgeon with symptoms referable to their disease
(either due to acute ﬂare-up or chronic stricture).
The qualitative analysis of the adequacy of bowel disten-
sion revealed that 74/98 cases were deemed to be of good
quality and 24 of average quality. None were considered to
be ofpoorqualitybyeitherReader.The degreeofdistal small
bowel distension was the key factor in determining adequacy
of the study however distension of the rest of the proximal
small bowel loops was also considered for determining ade-
quacy of the study as well as visualization of the subtending
mesentery within the intra-abdominal fat.
The level of conﬁdence regarding the overall diagnostic
outcomes was assumed to be high in 69/98 cases for Reader
1, intermediate in 25 cases, and low in 4 cases. For Reader
2 (who had more experience with this technique), the level
of conﬁdence regarding the ﬁndings was high in 93/98 cases,
intermediate in 5 cases, and low in 1 case.
A kappa score for interobserver variability for overall
determination of normal versus abnormal study was 0.84.
28 studies were considered normal by Reader 1 and 38 were
normalbyReader2,thoughinafewcases,Reader1indicated
abnormal study due to presence of signiﬁcant postoperative
changes with mild strictures which Reader 2 acknowledged
to be “normal” for this patient since the area of narrowing
was not causing moderate or high-grade obstruction.
In the abnormal studies, the kappa value for active in-
ﬂammation versus chronic stricture was 0.89 (Figures 1 and
2). The remaining kappa values for bowel segments aﬀected,
presence of skip lesions, presence of abscess, and presence
of ﬁstula are presented in Table 1. The segment of bowel
involvedwasseparatelyrecorded,and theresultsare depicted
in Table 2. The values for kappa ranged from 0.53 to 0.78 for
diﬀerent segments.
Reader 1 detected 21 patients who had skip areas com-
pared to 29 cases for Reader 2. 8 abscesses were detected by
Reader 1 compared to 5 by Reader 2, though there were 2
areasofpossiblephlegmonidentiﬁedbyReader2which were
not documented as frank abscesses. 9 cases of ﬁstula wereGastroenterology Research and Practice 3
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Figure 1: 38-year-old patient with Crohn’s disease with 8mm
thick slab reconstruction in coronal-oblique plane. There is mural
thickening of the ileum (black arrows), increased mesenteric fat
attenuation, and prominence of the vasa recta (white arrowhead),
all in keeping with active disease superimposed on chronic changes.
120 mm
Figure 2: Coronal thick-slab-reconstructed image in a patient with
documented Crohn’s disease with a chronic stricture causing low-
grade obstruction (white arrow).
detected by Reader 1 compared to 11 by Reader 2 (Figures
3(a) and 3(b)).
Incidental ﬁndings were also retrospectively recorded
from the original radiology reports. There were 3 patients
with incidentally discovered renal stones, 2 with calciﬁed
gallstones, 2 abdominal aortic aneurysms, 4 with signiﬁcant
fatty inﬁltration of the liver, and other incidental ﬁndings,
suchas2casesoflargeﬁbroidsand 2uncomplicatedinguinal
hernias.
Table 1: Kappa scores for MBCT results in patients with followup
of pathologically proven Crohn’s disease.
Characteristic Kappa value
Normal versus abnormalMBCT (overall) 0.84
Active inﬂammation versus stricture 0.89
Bowel segments involved 0.53–0.78
Presence of skip areas 0.62
Presence of abscess 0.75
Presence of ﬁstula 0.78
Poor agreement ≤ 0.20.
Fair agreement = 0.20 to 0.40.
Moderate agreement = 0.40 to 0.60.
Substantial agreement = 0.60 to 0.80.
Almost perfect agreement = 0.80 to 1.00.
Table 2:Bowelsegmentaﬀected by acuteorchronic crohn’sdisease.
Reader 1 Reader 2 Kappa
Duodenum 4 5 0.74
Jejunum 20 28 0.53
Ileum 51 51 0.78
Terminal ileum 20 28 0.70
Colon 28 35 0.62
Fifty-four of 98 patients underwent follow-up studies
within 4 months which were considered to be “gold stan-
dards.” 32 patients had surgery or colonoscopy with ileal
intubation and 24 patients had followup cross-sectional
imaging. 46 of 54 (85%) of cases that had “gold standard”
follow-up were in agreement with MBCT. In 7 of the 8 cases
of disagreement, the gold standard revealed a diﬀerent and
clinically signiﬁcant ﬁnding from the MBCT. This included
2 false positive ﬁndings, 5 false-negative ﬁnding, and 1 other
missed diagnosis.
In order to reduce radiation further in patients who
had previously underwent cross-sectional imaging and had
a known area of ﬁstula or abscess, only supine scanning
was obtained. Supine imaging was chosen rather than prone
since CT enterography and standard CECT are performed
in this manner and, thus, it was though that same patient
positioning would reduce diﬀerences in reporting due to
bowel loop position. Radiation exposure was estimated from
the recorded dose length product (DLP). The average DLP,
a value generated by the CT console was 391mGycm and
range was (187–908mGycm). Only supine imaging was
performed in 7 cases. Using the formula for estimated
radiation exposure E = DLP × 0.015 (abdominal conversion
factor) [7], this is equal to approximately 5.8mSv for the
combination of either prone and supine imaging or only
supine image acquisitions.
4.Discussion
There are many options for imaging Crohn’s disease. Small
bowel follow through and small bowel enteroclysiswere used
for many decades however due to overlapping bowel loops,4 Gastroenterology Research and Practice
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Figure 3: (a) 42-year-old male with Crohn’s disease. Raw supine, axial images acquired at 1.25mm slices prior to reconstruction on the 3D
workstation. (b) The 7mm thick, axial-reconstructed MBCT oblique-axial reformats demonstrate an enteroenteric ﬁstula (arrow). There is
also a skip lesion in small bowel on the left side of the pelvis (white arrows heads). (c) Follow-up imaging 1 year later demonstrates that this
enteroenteric ﬁstulous connection persists (arrow). On the current study, the skip lesion seen previously demonstrates increasing thickness
indicating worsening of disease (arrowheads).
abnormalities such as skip areas, or focal low-grade stricture
could be missed [8].
CT has become a common way of reproducibly eval-
uating the small bowel, especially since the advent of CT
enterography (CTE) [9, 10]. CTE is a cross-sectional imag-
ing modality which involve spositive intravenous contrast
and negative oral contrast. Various negative oral contrasts
have been evaluated including Volumen (Volumen; E-Z-
EM, Westbury, NY, USA, 0.1%w/v ultra-low-dose barium
with sorbitol, a nonabsorbable sugar alcohol), water, milk,
and polyethylene glycol [9–12], but obtaining adequate
distension is often challenging, particularly if there is no
acute obstruction.
Due to the relatively young age of many patients with
Crohn’s disease, radiation exposure is a concern. Radiation
dose from MBCT is lower than conventional CTE and
small bowel follow through (SBFT). Barium procedures
such as SBFT and enteroclysis have been reported to
have eﬀective doses of 13.68 ± 6.85mSv and 13.99 ±
7.57mSv, respectively [8]. CTE mean eﬀective doses have
been reported at 9.58mSv, with additional 1.13mSv for the
placement of the nasojejunal tube in CT enteroclysis [9]. In
comparison, radiation dose from a supine acquisition with
the above parameters has a dose length product (DLP) of
approximately 150mGycm, which equates to only 2.55mSv.
It does not use intravenous dye and is, therefore, safer forGastroenterology Research and Practice 5
patients and less expensive than CTE or standard contrast-
enhanced CT.
MRIisstartingtobecomemorecommonlyusedforsmall
bowelimaging,butMRenterographyusuallyrequirestheuse
of intravenous contrast which is associated with a low but
real risk of allergic reaction. Additionally, scan times are in
the range of 30–45 minutes compared to only a few seconds
when performing CT and antiperistaltic agents are usually
required [13–16].
Ultrasound has demonstrated high interobserver agree-
ment in a meta-analysis of prospective studies performed by
Horsthuis et al. [17], however, evaluation of the bowel using
ultrasoundcanstillbenegativelyaﬀectedbyoverlapping,air-
ﬁlled bowel loops. Additionally, detection and characteriza-
tion of complex enteroenteric ﬁstulas can be diﬃcult partly
due to heavy reliance on completeness of bowel evaluation
with inter- and intra-observer variations.
One of the key features of the MBCT protocol is the
ability to change the NI before starting the CT scan. Due
to the high intrinsic contrast resolution related to the
presence of the 9% Telebrix-38, the noise index can be
increased without losing the contrast resolution between the
hyperdense bowel lumen, the grey wall, and the surrounding
dark fat.
Complications of Crohn’s disease include acute or sub-
acute bowel obstruction. This may be due to either acute
inﬂammation orchronic stricture formation. Diﬀerentiation
of these two entities can be diﬃcult but is important because
management varies according to cause. For example, acute
inﬂammation is usually treated medically with anti-inﬂam-
matory agents, steroids, ASA-derivative agents, and immune
modulators [18] whereas chronic strictures may require
surgical resection. In our patient population who had an
abnormal ﬁnding on MBCT, the kappa value for active
inﬂammation (with or without underlying chronic com-
ponents) versus predominantly chronic strictures was 0.89
which is considered “almost perfect.” Active inﬂammation
in an area of chronic disease was considered as “active”
disease for the purposes of this study even if there were likely
components of both. Imaging features suggestive of active
inﬂammation included prominence of the gray subtending
mesentery, haziness in the fat around the bowel wall, and
ill deﬁnition between the edge of the wall and the adjacent
fat. Chronic stricture typically demonstrated a well-deﬁned
boarder between the wall and the fat with less prominence of
the underlying mesenteric vessels.
The kappa values for segment of bowel involved ranged
from 0.53 to 0.78. Part of the lower kappa results were
that certain bowel segments were infrequently involved
(duodenum). Also, the deﬁnition of neoterminal ileum and
distal ileum was controversial, particularly in postoperative
patients and there was some interobserver disagreement in
cases, though on review of the images, the readers were
indicating the same area of interest in many instances.
In the subgroup of patients who underwent “gold
standard” followup, there were 8 discrepant cases. In the
ﬁrst case, MBCT described active Crohn’s disease of the
terminal ileum. At surgery, this was found to be a Meckel’s
diverticulitis. In the second false-positive MBCT case, active
Crohn’s disease of the terminal ileum was found to represent
a stricture 3 months later, however, the patient had interval
medical therapy and, thus, this may not be a truly discrepant
c a s e ,r a t h e r ,t h ea c t i v ei n ﬂ a m m a t i o nm a yh a v ec h a n g e dt o
scarring and ﬁbrosis in the interim. 3 cases were described
as being normal on the original MBCT reports. In one
case, colonoscopy with ileal intubation 3.5 months later
demonstrated a single aphthous ulcer in the terminal ileum.
In another case which underwent ileoscopy 3 months later, a
small ulcer was found 5cm from the stoma in a patient with
prior colectomy. In the third case, mild inﬂammation was
demonstratedoncolonoscopyattheneoterminalileumafew
days after “normal” MBCT. In the group of false-negative
M B C T ,i no n ec a s e ,n ol e a kw a sd e t e c t e db yM B C Tb u t2
months later, the patient was taken to the operating theatre
because of persistent fevers and pain, and a small leak at the
anastomosis was found and repaired. In another case, MBCT
was reported as normal but colonoscopy identiﬁed Crohn’s
colitis. In retrospect, MBCT did demonstrate this ﬁnding,
though this study is geared to opacify and evaluate the small
bowel rather than focus on the colon. In the ﬁnal discrepant
case, MBCT correctly identiﬁed active Crohn’s disease of
the terminal ileum but did not detect a pancreatic mass.
A follow-up CECT 3 months later showed the ill-deﬁned,
hypoenhancing pancreatic mass from which the patient later
died.
Since there is no intravenous contrast used for this
MBCT, solid organs cannot be adequately evaluated. This
type of CT protocol should not be used in older patients
with chronic anemia or nonspeciﬁc abdominal symptoms.
It should also not be used in cases of suspected malignancy.
Additionally, it should not be used in patient with acute
GI bleed, since there is no intravenous contrast used and
the hyperdense oral contrast would obscure subsequently
injected contrast into the lumen of the bowel.
One of the limitations of this study is its retrospective
nature, andtherewas no gold-standardcomparison available
for all the cases. Thus, the true sensitivity, speciﬁcity, and
accuracy of MBCT could not be calculated. Most patients
diagnosed with acute inﬂammation are treated medically
and, thus, there is no consistent surgical intervention or
pathologic diagnosis. We did not divide acute or chronic
disease as a separate category, but simply categorized them
as acute inﬂammation. However, of the patients who did
undergo other imaging or intervention, there was 85%
agreement as discussed above.
We also did not quantify the degree of distension of the
bowel. This is technically diﬃcult, particularly in patients
who have had prior bowel resection and in patients with
strictures causing partial obstruction. A more quantitative
determination of the degree of bowel distension could be
attempted in future studies.
5.Conclusions
MBCT is a low-radiation technique used to determine
the involved bowel segments, presence of obstruction, and
degree of disease activity in patients with known Crohn’s6 Gastroenterology Research and Practice
disease. For this indication, MBCT is a highly reproducible
imaging technique with good and very good kappa scores
for evaluating parameters such as presence of active disease
versus stricture, the presence of abscess, strictures, and skip
lesions.
Further study with prospective trials should be con-
ducted, with direct comparison to CTE and MRE with
colonoscopic or surgical comparison.
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